175 related articles for article (PubMed ID: 22461567)
1. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.
Smushkin G; Sathananthan M; Sathananthan A; Dalla Man C; Micheletto F; Zinsmeister AR; Cobelli C; Vella A
Diabetes; 2012 May; 61(5):1082-9. PubMed ID: 22461567
[TBL] [Abstract][Full Text] [Related]
2. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion.
Müssig K; Staiger H; Machicao F; Kirchhoff K; Guthoff M; Schäfer SA; Kantartzis K; Silbernagel G; Stefan N; Holst JJ; Gallwitz B; Häring HU; Fritsche A
Diabetes; 2009 Jul; 58(7):1715-20. PubMed ID: 19366866
[TBL] [Abstract][Full Text] [Related]
3. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
Schäfer SA; Tschritter O; Machicao F; Thamer C; Stefan N; Gallwitz B; Holst JJ; Dekker JM; 't Hart LM; Nijpels G; van Haeften TW; Häring HU; Fritsche A
Diabetologia; 2007 Dec; 50(12):2443-50. PubMed ID: 17661009
[TBL] [Abstract][Full Text] [Related]
4. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion.
Schäfer SA; Müssig K; Staiger H; Machicao F; Stefan N; Gallwitz B; Häring HU; Fritsche A
Diabetologia; 2009 Jun; 52(6):1075-82. PubMed ID: 19330314
[TBL] [Abstract][Full Text] [Related]
5. Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.
Heni M; Ketterer C; Thamer C; Herzberg-Schäfer SA; Guthoff M; Stefan N; Machicao F; Staiger H; Fritsche A; Häring HU
Diabetes; 2010 Dec; 59(12):3247-52. PubMed ID: 20802253
[TBL] [Abstract][Full Text] [Related]
6. Common variants in the type 2 diabetes KCNQ1 gene are associated with impairments in insulin secretion during hyperglycaemic glucose clamp.
van Vliet-Ostaptchouk JV; van Haeften TW; Landman GW; Reiling E; Kleefstra N; Bilo HJ; Klungel OH; de Boer A; van Diemen CC; Wijmenga C; Boezen HM; Dekker JM; van 't Riet E; Nijpels G; Welschen LM; Zavrelova H; Bruin EJ; Elbers CC; Bauer F; Onland-Moret NC; van der Schouw YT; Grobbee DE; Spijkerman AM; van der A DL; Simonis-Bik AM; Eekhoff EM; Diamant M; Kramer MH; Boomsma DI; de Geus EJ; Willemsen G; Slagboom PE; Hofker MH; 't Hart LM
PLoS One; 2012; 7(3):e32148. PubMed ID: 22403629
[TBL] [Abstract][Full Text] [Related]
7. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study.
Sathananthan A; Man CD; Micheletto F; Zinsmeister AR; Camilleri M; Giesler PD; Laugen JM; Toffolo G; Rizza RA; Cobelli C; Vella A
Diabetes Care; 2010 Sep; 33(9):2074-6. PubMed ID: 20805279
[TBL] [Abstract][Full Text] [Related]
9. Comparison of an oral mixed meal plus arginine and intravenous glucose, GLP-1 plus arginine to unmask residual islet function in longstanding type 1 diabetes.
Uitbeijerse BS; Nijhoff MF; de Koning EJP
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E673-E680. PubMed ID: 38446636
[TBL] [Abstract][Full Text] [Related]
10. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
[TBL] [Abstract][Full Text] [Related]
11. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women.
Reyes-López R; Pérez-Luque E; Malacara JM
Diabetes Metab Res Rev; 2014 Nov; 30(8):701-6. PubMed ID: 24639413
[TBL] [Abstract][Full Text] [Related]
12. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
[TBL] [Abstract][Full Text] [Related]
13. The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load.
Holmkvist J; Banasik K; Andersen G; Unoki H; Jensen TS; Pisinger C; Borch-Johnsen K; Sandbaek A; Lauritzen T; Brunak S; Maeda S; Hansen T; Pedersen O
PLoS One; 2009 Jun; 4(6):e5872. PubMed ID: 19516902
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Diabetes-Associated Variation in
Adams JD; Egan AM; Laurenti MC; Schembri Wismayer D; Bailey KR; Cobelli C; Dalla Man C; Vella A
Metab Syndr Relat Disord; 2022 Aug; 20(6):329-335. PubMed ID: 35442800
[No Abstract] [Full Text] [Related]
15. Genetic determinants of circulating GIP and GLP-1 concentrations.
Almgren P; Lindqvist A; Krus U; Hakaste L; Ottosson-Laakso E; Asplund O; Sonestedt E; Prasad RB; Laurila E; Orho-Melander M; Melander O; Tuomi T; Holst JJ; Nilsson PM; Wierup N; Groop L; Ahlqvist E
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093273
[TBL] [Abstract][Full Text] [Related]
16. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
[TBL] [Abstract][Full Text] [Related]
17. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
[TBL] [Abstract][Full Text] [Related]
18. Impact of common type 2 diabetes risk gene variants on future type 2 diabetes in the non-diabetic population in Korea.
Park SE; Lee WY; Oh KW; Baek KH; Yoon KH; Kang MI; Son HY; Lee WC
J Hum Genet; 2012 Apr; 57(4):265-8. PubMed ID: 22377714
[TBL] [Abstract][Full Text] [Related]
19. A model of GLP-1 action on insulin secretion in nondiabetic subjects.
Dalla Man C; Micheletto F; Sathananthan A; Rizza RA; Vella A; Cobelli C
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1115-21. PubMed ID: 20179243
[TBL] [Abstract][Full Text] [Related]
20. A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.
Wood AR; Jonsson A; Jackson AU; Wang N; van Leewen N; Palmer ND; Kobes S; Deelen J; Boquete-Vilarino L; Paananen J; Stančáková A; Boomsma DI; de Geus EJC; Eekhoff EMW; Fritsche A; Kramer M; Nijpels G; Simonis-Bik A; van Haeften TW; Mahajan A; Boehnke M; Bergman RN; Tuomilehto J; Collins FS; Mohlke KL; Banasik K; Groves CJ; McCarthy MI; ; Pearson ER; Natali A; Mari A; Buchanan TA; Taylor KD; Xiang AH; Gjesing AP; Grarup N; Eiberg H; Pedersen O; Chen YD; Laakso M; Norris JM; Smith U; Wagenknecht LE; Baier L; Bowden DW; Hansen T; Walker M; Watanabe RM; 't Hart LM; Hanson RL; Frayling TM
Diabetes; 2017 Aug; 66(8):2296-2309. PubMed ID: 28490609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
